Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Dosoretz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer|November 26, 2010
Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivationPaul L Nguyen, Ming H Chen, Samuel Z Goldhaber, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selectionDaniel A Wattson, Ming-Hui Chen, Judd W Moul, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate sizePaul L Nguyen, Ming H Chen, Toni K Choueiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarctionPaul L Nguyen, Ming-Hui Chen, Joshua A Beckman, et al.
Brachytherapy|May 9, 2013
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancerArti Parekh, Ming-Hui Chen, Anthony V D'Amico, et al.
Brachytherapy|December 21, 2004
Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysisConstantine A Mantz, Daniel E Dosoretz, James H Rubenstein, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer|November 26, 2010
Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivationPaul L Nguyen, Ming H Chen, Samuel Z Goldhaber, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selectionDaniel A Wattson, Ming-Hui Chen, Judd W Moul, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate sizePaul L Nguyen, Ming H Chen, Toni K Choueiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2011
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarctionPaul L Nguyen, Ming-Hui Chen, Joshua A Beckman, et al.
Brachytherapy|May 9, 2013
Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancerArti Parekh, Ming-Hui Chen, Anthony V D'Amico, et al.
Brachytherapy|December 21, 2004
Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysisConstantine A Mantz, Daniel E Dosoretz, James H Rubenstein, et al.
Pageof 2